PerkinElmer Posts 15 Percent Q4 Revenue Growth | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its fourth-quarter revenues increased 15 percent, or 6 percent organically, over the fourth quarter of 2010.

The Waltham, Mass.-based analytical tools firm brought in total revenues of $540.2 million for the three-month period ended Jan. 1, 2012, compared to $470 million for the fourth quarter of 2010. It beat analysts' consensus estimate for revenues of $537.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.